Inovio Pharmaceuticals (INO) EBT Margin (2010 - 2025)
Inovio Pharmaceuticals' EBT Margin came in at -129167.54% for FY2025, down 79658.10 percentage points from -49509.43% in FY2024.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) EBT Margin (2010 - 2025) Analysis & Trends
Going back to FY2009, Inovio Pharmaceuticals' EBT Margin data covers 17 years.
- EBT Margin has declined in each of the last three years, with a five-year change of -126969.65 percentage points (FY2020 to FY2025).
- The FY2025 figure represents the lowest annual EBT Margin in data going back to FY2009.
- Per Business Quant, earlier years put EBT Margin at -49509.43% in FY2024 (-33269.56 pp), -16239.87% in FY2023 (-13534.30 pp), -2705.57% in FY2022 (+14379.82 pp) and -17085.39% in FY2021 (-14887.50 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Inovio Pharmaceuticals | 99.58 Mn | 99.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -37,100.30% |
| Dec 31, 2024 | -16,682.03% |
| Jun 30, 2024 | -31,648.39% |
| Dec 31, 2023 | -24,357.91% |
| Sep 30, 2023 | -8,734.77% |
| Jun 30, 2023 | -15,725.26% |
| Mar 31, 2023 | -35,364.76% |
| Dec 31, 2022 | -43,687.24% |
| Sep 30, 2022 | -412.75% |
| Jun 30, 2022 | -13,831.97% |
| Mar 31, 2022 | -38,633.12% |
| Dec 31, 2021 | -12,745.28% |
| Sep 30, 2021 | -20,627.17% |
| Jun 30, 2021 | -30,107.31% |
| Mar 31, 2021 | -14,541.86% |
| Dec 31, 2020 | -401.66% |
| Sep 30, 2020 | 8,862.39% |
| Jun 30, 2020 | -48,007.84% |
| Mar 31, 2020 | -2,496.50% |
| Dec 31, 2019 | -13,680.42% |
API Access
Inovio Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();